Scatena, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 2.718
EU - Europa 2.715
AS - Asia 1.921
SA - Sud America 392
AF - Africa 49
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.804
Nazione #
US - Stati Uniti d'America 2.636
SG - Singapore 763
CN - Cina 661
DE - Germania 606
RU - Federazione Russa 535
SE - Svezia 366
BR - Brasile 328
UA - Ucraina 317
IT - Italia 166
PL - Polonia 154
FR - Francia 124
IE - Irlanda 117
GB - Regno Unito 102
TR - Turchia 100
FI - Finlandia 91
VN - Vietnam 82
ID - Indonesia 76
IN - India 72
CA - Canada 48
JP - Giappone 27
ES - Italia 25
BD - Bangladesh 24
BE - Belgio 23
HK - Hong Kong 22
AR - Argentina 20
KR - Corea 19
MX - Messico 18
NL - Olanda 18
IQ - Iraq 17
MA - Marocco 13
ZA - Sudafrica 13
VE - Venezuela 10
PK - Pakistan 9
RO - Romania 9
AT - Austria 8
CH - Svizzera 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
CO - Colombia 7
IR - Iran 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 5
AU - Australia 5
BY - Bielorussia 5
CL - Cile 5
IL - Israele 5
KE - Kenya 5
PT - Portogallo 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
UZ - Uzbekistan 5
DZ - Algeria 4
LT - Lituania 4
MY - Malesia 4
UY - Uruguay 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
PE - Perù 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
LU - Lussemburgo 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
ME - Montenegro 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
Totale 7.804
Città #
Chandler 406
Singapore 297
Ashburn 233
Jacksonville 157
Warsaw 150
Beijing 117
San Mateo 116
Dublin 112
Nanjing 106
Wilmington 84
New York 82
Woodbridge 69
Ann Arbor 68
The Dalles 66
Jakarta 65
Houston 63
Izmir 62
Los Angeles 61
Fairfield 58
Hefei 58
Dearborn 57
Boston 47
Lawrence 45
Seattle 44
Redmond 43
Cattolica 37
Chicago 33
Moscow 33
São Paulo 31
Bremen 27
Mountain View 25
Ho Chi Minh City 24
Cambridge 23
Frankfurt am Main 23
Kunming 23
Redwood City 23
Shanghai 23
Helsinki 22
Hanoi 21
Munich 21
Boardman 20
Hong Kong 20
Nürnberg 20
Kent 19
Zhengzhou 19
Detroit 18
Milan 18
Nanchang 18
Princeton 18
Hangzhou 17
Montreal 17
Shenyang 17
Rome 16
Brussels 15
Hebei 15
Tokyo 15
Guangzhou 14
Dallas 13
Lancaster 13
Toronto 13
University Park 13
London 12
Marseille 12
Philadelphia 12
Brooklyn 11
Buffalo 11
Jiaxing 11
Pune 11
Seoul 11
Changsha 10
Johannesburg 10
Belo Horizonte 9
Tianjin 9
Turku 9
Edinburgh 8
Santa Clara 8
Düsseldorf 7
Lanzhou 7
Simi Valley 7
Atlanta 6
Chengdu 6
Curitiba 6
Indiana 6
Madrid 6
Norwalk 6
Renton 6
San Jose 6
Baghdad 5
Biên Hòa 5
Brasília 5
Centrale 5
Council Bluffs 5
Dhaka 5
Istanbul 5
Manchester 5
Minsk 5
Ottawa 5
Phoenix 5
Portsmouth 5
Rio de Janeiro 5
Totale 3.691
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 587
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 378
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 184
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 178
CA 19-9: Biochemical and Clinical Aspects 176
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 169
Advances in Cancer Stem Cell Biology 167
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 160
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 154
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 153
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 149
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 146
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 145
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 142
An update on pharmacological approaches to neurodegenerative diseases. 140
A Critical Approach to Clinical Biochemistry of Chromogranin A 139
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 138
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 137
Immunological role of IgG subclasses 137
Advances in Mitochondrial Medicine 134
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 130
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 130
CA 19-9: Biochemical and Clinical Aspects 130
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 128
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 123
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 121
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 121
Cancer stem cells: the development of new cancer therapeutics 115
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 115
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 115
Immunological role of IgG subclasses 113
Oxygen transport by Fetal Bovine Hemoglobin 109
A critical approach to clinical biochemistry of Chromogranin A 109
The role of CA 125 as tumor marker: biochemical and clinical aspects 108
Cancer Stem Cells: An Innovative Therapeutic Approach 107
CA 19-9: Biochemical and Clinical Aspects 107
Cancer Biomarkers: A Status Quo 104
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 103
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 101
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 100
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 98
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 95
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 95
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 94
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 92
Glycolytic enzyme inhibitors in cancer treatment. 91
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 91
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 88
Mitochondrial respiration and differentiation 88
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 86
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 84
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 83
Cellular respiration and dedifferentiation 82
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 81
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 77
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 76
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 71
Cytotoxicity of a new endodontic filling material 70
Mitochondria and drugs 69
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 67
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 65
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 56
Nitroflurbiprofen (NicOx). 53
Totale 7.854
Categoria #
all - tutte 29.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 53 61 5 81 18 97 14
2021/2022567 48 69 9 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/20251.120 34 25 85 35 98 43 33 74 156 138 189 210
2025/20261.421 421 103 171 279 406 41 0 0 0 0 0 0
Totale 7.854